CDT Equity share price logo

CDT Equity

NASDAQ: CDT

$0.25

-0.09

(-27.49%)

as on

CDT Equity Stock Performance

as on September 12, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.23
    $0.26
    downward going graph

    8.00%

    Downside

    4.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.58
    $2,360.00
    downward going graph

    -132.04%

    Downside

    943900.00%

    Upside

    downward going graph

CDT Equity share price movements today

Previous Close
$0.34
Open
$0.25
Volume
4.4M
Market Cap
$8.4M
Day's Low - High
$0.23 - $0.26
52 Week Low - High
$0.58 - $2,360.00

CDT Equity Historical Returns

1 Month Return
-80.7 %
3 Month Return
-91.67 %
1 Year Return
-99.95 %
3 Year Return
0 %
5 Year Return
0 %

CDT Equity Stock Fundamentals & Key Indicators

Check CDT Equity market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.4M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-69.68%

CDT Equity vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CDT Equity with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
CDT Equity image
CDT Equity
NA$8.4MNANA0.00%NA
Revolution Medicines image
Revolution Medicines
BUY$44.6B614.61%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$138.4B181.2%30.5486.04%NA
Moderna image
Moderna
BUY$56.0B-69.82%-16.99-12.57%NA
Regeneron image
Regeneron
BUY$85.2B24.16%19.2884.86%45.660000000000004%

Stock Returns calculator for CDT Equity Stock including INR - Dollar returns

The CDT Equity stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

CDT Equity investment value today

Current value as on today

₹22

Returns

-₹99,978

(-99.98%)

Returns from CDT Equity Stock

-₹99,979 (-99.98%)

Dollar Impact

₹2 (+0.00%)

Indian Investors' Interest in CDT Equity Stock

Search interest for CDT Equity Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

CDT Equity Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
535
-1,345
654
1,076
624
671
698
2,715
696
750
Gross Profit
201
-695
0
0
0
0
0
0
258
301
Operating Income
-2
-3
-5
-3
-3
-4
-7
-21
77
117
EBITDA
-3
18
-6
0
-4
-5
-6
-18
108
159
Interest Expense
0
0
0
0
0
0
0
0
13
40
Depreciation
-
-
0
0
0
0
-1
2
0
0
Income Before Tax
-3
-5
-6
-2
-4
-6
-7
-21
62
85
Income Tax Expense
-8
-11
-60
0
-10
-5
0
29
11
16
Net Income
-3
-5
-6
-2
-4
-6
-7
-21
51
68
Net Profit Margin
-0.66%
0.40%
-0.99%
-0.22%
-0.76%
-0.90%
-1.02%
-0.79%
7.33%
9.14%

CDT Equity Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
922
2,715
Gross Profit
-
-
-
0
1,031
Operating Income
-3
-3
-5
-15
-36
EBITDA
-3
-4
3
-15
-36
Interest Expense
-
-
0
1
0
Depreciation
-
-
-
0
2
Income Before Tax
-3
-4
2
-17
-39
Income Tax Expense
0
0
0
-29
29
Net Income
-3
-4
0
-17
-39
Net Profit Margin
0.00%
0.00%
0.00%
-1.93%
-1.44%

CDT Equity Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-6
-2
51
-6
56
134
51
68
Operating Cash Flow
-1
-1
-3
7
-2
105
-4
-18
42
Investing Cash Flow
0
0
0
-24
0
-39
0
-44
-40
Financing Cash Flow
0
1
4
-96
3
-54
1
-53
19
Change in Cash
-1
0
0
-111
1
12
-2
-117
20

CDT Equity Annual Cash Flow

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
0
-17
-39
Operating Cash Flow
-2
-7
-9
-15
Investing Cash Flow
0
0
0
0
Financing Cash Flow
2
10
6
17
Change in Cash
0
4
-3
0

Mutual Funds that own CDT Equity Stock

Check out the Mutual Funds with significant holdings in CDT Equity.

Funds
Holdings
Shares Held
ProFunds
0.041567%
327

Global Institutional Holdings in CDT Equity

Funds
Holdings
Financial Management Professionals Inc
0.16%
Tower Research Capital LLC
0%
Morgan Stanley - Brokerage Accounts
0%
Apollon Wealth Management, LLC
0%
SBI Securities Co Ltd
0%
See all

CDT Equity News & Key Events

  • img

    Today's Timeline - 01 September

    Tue, 05:57 PM

    -

    James Bligh appointed CEO of CDT Equity amid leadership changes; former CEO Dr. Andrew Regan resigned.

    Wed, 03:03 AM

    -

    CDT Equity stockholders approved share issuance, improving Nasdaq compliance status and increasing total shares outstanding to 13,693,866.

Insights on CDT Equity

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 512.4% return, outperforming this stock by 612.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CDT stock has moved down by -60.0%

About CDT Equity

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
OrganisationCDT Equity
Headquarters4581 Tamiami Trail North, Naples, FL, United States, 34103
IndustryBiotechnology
CEODr. Andrew Regan
E-voting on sharesClick here to vote

Key Management of CDT Equity

Name

Title

Dr. Andrew Regan

Founder, CEO & Director

FAQs

What is CDT Equity share price today?

CDT Equity share price today is $0.25 as on at the close of the market. CDT Equity share today touched a day high of $0.26 and a low of $0.23.

What is the 52 week high and 52 week low for CDT Equity share?

CDT Equity share touched a 52 week high of $2,360.00 on and a 52 week low of $0.58 on . CDT Equity stock price today i.e. is closed at $0.25,which is 99.99% down from its 52 week high and -56.90% up from its 52 week low.

What is CDT Equity's market capitalisation today?

CDT Equity market capitalisation is $0.00T as on .

How to invest in CDT Equity Stock (CDT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for CDT Equity on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CDT Equity Shares that will get you 6.0000 shares as per CDT Equity share price of $0.25 per share as on September 12, 2026 at 8:45 am IST.

What is the minimum amount required to buy CDT Equity Stock (CDT) from India?

Indian investors can start investing in CDT Equity (CDT) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in CDT Equity stock (as per the Rupee-Dollar exchange rate as on ). Based on CDT Equity share’s latest price of $0.25 as on September 12, 2026 at 8:45 am IST, you will get 40.0000 shares of CDT Equity. Learn more about fractional shares .